March 18, 2016

March 18, 2016

Copy That
The Business Observer – March 18
One key component: It uses mapping software to remotely monitor client’s printers and copiers. Its core market is mid-size businesses, but the client list includes some large entities, such as Moffitt Cancer Center and law firm Carlton Fields.

PatientsLikeMe and M2Gen Announce Partnership
Technology Networks – March 18
The partnership aims to advance cancer research by combining real-world, patient-reported outcomes shared by members of PatientsLikeMe with the molecular and clinical data shared by patients enrolled in the Total Cancer Care® program at Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center.

Expert on PD-L1/CTLA-4 Blockade and Future of Immunotherapy in Lung Cancer
OncLive – March 17
To learn more about the trial and benefits of dual PD-L1/CTLA-4 blockade in NSCLC, OncLive spoke with lead study author Scott J. Antonia, MD, chair of the Department of Thoracic Oncology at Moffitt Cancer Center.

Immunotherapy and MSI Status in Colorectal Cancer
OncLive – March 17
Richard Kim, MD: I think we do have several trials, I think probably more trials than the patient right now currently at this time

UK Study takes on Breast tumors
KXII – March 17
Ismail-Kan is a breast cancer specialist at Moffitt Cancer Center. Che says combination therapies are standard in fact, the same combination studied in this trial is often given to late stage her2 patients because it )s not approved for early use. she calls the results promising but not game changing

Study: Breast cancer treatment kills tumors in 11 days
WTSP – March 16
Dr. Roohi Ismail-Khan, a breast cancer specialist at Moffitt Cancer Center, calls the results of the study promising, but not game changing.

Go Guide for March 17
Go Ocala – March 16
TIARA BALL FOR CHARITY: Ocala Royal Dames' 30th annual Tiara Ball benefiting cancer research and education at UF Cancer Center, Moffitt Cancer Center and the College of Central Florida, 6:30 p.m. Saturday, Golden Ocala Golf & Equestrian Club, 8300 NW 31st Lane Road, Ocala. $125, formal attire required. (622-7363)

Vyxeos Improves Survival in Patients With High-risk AML
Cancer Therapy Advisor – March 16
“The overall survival advantage seen with CPX-351 compared to 7+3, along with a superior response rate and no increase in serious toxicity indicates that we'll likely have a new standard of care for treating older patients with secondary AML,” said principal investigator Jeffrey E. Lancet, MD, senior member and chief of the Leukemia/Myelodysplasia Program at Moffitt Cancer Center. 

Prostate Health: What New Discoveries Mean for African-Americans
Media Planet – March 16
A pioneering study by Kosj Yamoah, M.D., Ph.D., of the Moffitt Cancer Center, identified six new genetic signatures—called “biomarkers”—linked with the aggressive tumors found in African-American men with prostate cancer.

Moffitt, M2Gen leader wins ‘Hall of Fame’ honors
Hong King Herald – March 15
William Dalton, founder and CEO of M2Gen, is one of seven innovators elected to the Florida Inventors Hall of Fame.

Moffitt, M2Gen leader wins ‘Hall of Fame’ honors
Tampa Bay Business Journal – March 15
William Dalton, founder and CEO of M2Gen, is one of seven innovators elected to the Florida Inventors Hall of Fame.

US Policy Toward Cuba
CSPAN3 – March 15
Rep. Kathy Castor: “My cancer center in Florida, the top rated cancer center, the Moffitt Cancer Center and other institutions across America are engaging now with the doctors and medical community in Cuba to help find treatments and cures for cancer and diabetes.”

Relay for Life spotlights efforts to cure cancer
Polk County Democrat – March 15
Six years ago her husband, Fred, had gotten esophageal cancer and was sent to Moffitt Cancer Center.

Switching therapy in Chronic Myeloid Leukemia
OncLive – March 15
Javier Pinilla-Ibarz, MD, PhD: I think we’re going to discuss [that there are] two different main reasons why we change TKI therapy: tolerance and lack of response.

UF microbiology professor inducted into Florida Inventors Hall of Fame
UF News – March 15
Joining Muzyczka as 2016 inductees are Nobel Laureate Andrew Schally of the University of Miami; Jacqueline Quinn, environmental engineer at NASA’s Kennedy Space Center; William Dalton of M2Gen, a subsidiary of Moffitt Cancer Center & Research Institute for his revolutionizing developments in cancer treatment; Yogi Goswami of the University of Central Florida, for his pioneering contributions and technology development related to solar energy and indoor air quality; Alan Marshall of Florida State University, inventor of Fourier Transform Ion Cyclotron Resonance mass spectrometry; and MJ Soileau of the University of Central Florida, for his innovative research in the advancement of high energy laser optics used by the U.S. Department of Defense.

Celator Pharma Surprises With Blood Cancer Drug Survival Benefit
MSN – March 15
"The overall survival advantage seen with CPX-351 [Vyxeos] compared to 7+3, along with a superior response rate and no increase in serious toxicity indicates that we'll likely have a new standard of care for treating older patients with secondary AML," said Dr. Jeffrey E. Lancet, a blood cancer specialist at the Moffitt Cancer Center and the principal investigator for the study, in a statement.

Moffitt partnership one reason Tampa needs Cuba flights, backers say
Tampa Tribune – March 14
The H. Lee Moffitt Cancer Center & Research Institute has been exploring partnerships with counterparts in Cuba, including an institute known for developing a promising vaccine for lung cancer.

Why this ‘astonishing’ new treatment doesn’t signal the end of breast cancer
SELF – March 14
That’s actually not as good as the response rate for the current standard of care, medical oncologist Hatem Soliman, M.D., an assistant member in the Moffitt Cancer Center’s Breast Oncology Department, tells SELF. 

Ease up on aggressive Mesothelioma treatments to prolong lives
Mesothelioma Help – March 14
Researchers at Moffitt Cancer Center in Tampa, Florida, led by Robert Gatenby, M.D., study author and leader of the Cancer Biology & Evolution Program at Moffitt, want to attack cancer with adaptive therapy, which focuses on keeping resistant cells in check by maintaining an army of chemo-sensitive cells alive.

BRHS bans together to raise money for the Carrier family
Longboat Key Observer – March 13
Carrier and his wife, Kerrie, who are both music teachers at Braden River High School, have been regularly driving to the Moffitt Cancer Center in Tampa for Kris' chemotherapy treatments.

Combinationof Immune Checkpoint Blockers Shows Promise in Lung Cancer
Oncology Nurse Advisor – March 11
"The results suggest that this combination has potential as a treatment option for patients with PD-L1-negative tumors whose needs are not addressed by current therapies, including immunotherapies," said Scott J. Antonia, MD, PhD, chair of the Thoracic Oncology Department at H Lee Moffitt Cancer Center in Tampa, Florida, and co-lead author of the study. "It also reinforces the benefits of combination therapy in oncology."

AZ and Roche fund PatientsLikeMe cancer patient outcomes study
PM Live – March 11
The online community is working with informatics firm M2Gen on the project, which aims to shed new light on the factors that may affect outcomes and quality of life.


Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.